Rivaroxabandirect factor Xainhibitor prototypethat inhibits plateletactivation andformation of fibrinclotting by inhibitionof factor Xa3QSEN Alert: Thenurse should holdthe dose of warfarinif the INR is abovethis number andnotify the healthcare providerIdarucizumabAntidotefordabigatranProtamineSulfateAntidoteforheparinAminocaproicacidReversal ofthrombolytic agentused in cardiacsurgery, blooddisorders, hepaticcirrhosis,prostatectomy, andneoplastic disordersPCCReversal ofwarfarin overdosewith acute majorbleeding or inneed of emergentsurgeryDisseminatedintravascularcoagulation(DIC)Heparin is used totreat this life-threatening conditioncharacterized bywidespread clotting,which depletes theblood of coagulationfactors.Heparininhibits theconversion ofprothrombin tothrombin andprevents thrombusformationaPTTlaboratory testused to see ifheparin iswithintherapeuticrangeHemorrhagemajor sideeffect ofHeparintherapyThrombolysisDissolutionof bloodclotsDVTand PEHeparin isgivenprophylacticallyto patients toprevent thesePTTandINRLaboratorytests used tomanagetherapeuticrange ofwarfarindabigatranThe onlyoral directthrombininhibitoralteplaseprototypethrombolyticdrugwarfarinPrototypevitamin KantagonistVitaminKantidoteforwarfarinClopidogrelprototype Adenosinediphosphate receptorantagonist thatirreversibly blocks theADP receptor onplatelet cell surface.HomeostasisProcess thatmaintains theintegrity ofthe vascularcompartment.ThrombolyticDrugsagentsthatdissolveblood clotsActionofwarfarinActs in theliver topreventsynthesis ofvitamin KHeparin inducedthrombocytopenia(HIT)A potentially life-threateningcomplication of heparinadministration leadingto a decrease inplatelet count anddetectable HITantibodiesPlasminogenAn inactive proteinpresent in many bodytissues and fluids thatis bound to fibrin andbecomes acomponent of a bloodclottranexamicacidReversal ofthrombolytic agentused for short periodsin patients withhemophilia to preventor decrease breedingform tooth extraction ormenorrhagia.Rivaroxabandirect factor Xainhibitor prototypethat inhibits plateletactivation andformation of fibrinclotting by inhibitionof factor Xa3QSEN Alert: Thenurse should holdthe dose of warfarinif the INR is abovethis number andnotify the healthcare providerIdarucizumabAntidotefordabigatranProtamineSulfateAntidoteforheparinAminocaproicacidReversal ofthrombolytic agentused in cardiacsurgery, blooddisorders, hepaticcirrhosis,prostatectomy, andneoplastic disordersPCCReversal ofwarfarin overdosewith acute majorbleeding or inneed of emergentsurgeryDisseminatedintravascularcoagulation(DIC)Heparin is used totreat this life-threatening conditioncharacterized bywidespread clotting,which depletes theblood of coagulationfactors.Heparininhibits theconversion ofprothrombin tothrombin andprevents thrombusformationaPTTlaboratory testused to see ifheparin iswithintherapeuticrangeHemorrhagemajor sideeffect ofHeparintherapyThrombolysisDissolutionof bloodclotsDVTand PEHeparin isgivenprophylacticallyto patients toprevent thesePTTandINRLaboratorytests used tomanagetherapeuticrange ofwarfarindabigatranThe onlyoral directthrombininhibitoralteplaseprototypethrombolyticdrugwarfarinPrototypevitamin KantagonistVitaminKantidoteforwarfarinClopidogrelprototype Adenosinediphosphate receptorantagonist thatirreversibly blocks theADP receptor onplatelet cell surface.HomeostasisProcess thatmaintains theintegrity ofthe vascularcompartment.ThrombolyticDrugsagentsthatdissolveblood clotsActionofwarfarinActs in theliver topreventsynthesis ofvitamin KHeparin inducedthrombocytopenia(HIT)A potentially life-threateningcomplication of heparinadministration leadingto a decrease inplatelet count anddetectable HITantibodiesPlasminogenAn inactive proteinpresent in many bodytissues and fluids thatis bound to fibrin andbecomes acomponent of a bloodclottranexamicacidReversal ofthrombolytic agentused for short periodsin patients withhemophilia to preventor decrease breedingform tooth extraction ormenorrhagia.

Chapter 9 Drug Therapy for Coagulation Disorders - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
  1. direct factor Xa inhibitor prototype that inhibits platelet activation and formation of fibrin clotting by inhibition of factor Xa
    Rivaroxaban
  2. QSEN Alert: The nurse should hold the dose of warfarin if the INR is above this number and notify the health care provider
    3
  3. Antidote for dabigatran
    Idarucizumab
  4. Antidote for heparin
    Protamine Sulfate
  5. Reversal of thrombolytic agent used in cardiac surgery, blood disorders, hepatic cirrhosis, prostatectomy, and neoplastic disorders
    Aminocaproic acid
  6. Reversal of warfarin overdose with acute major bleeding or in need of emergent surgery
    PCC
  7. Heparin is used to treat this life-threatening condition characterized by widespread clotting, which depletes the blood of coagulation factors.
    Disseminated intravascular coagulation (DIC)
  8. inhibits the conversion of prothrombin to thrombin and prevents thrombus formation
    Heparin
  9. laboratory test used to see if heparin is within therapeutic range
    aPTT
  10. major side effect of Heparin therapy
    Hemorrhage
  11. Dissolution of blood clots
    Thrombolysis
  12. Heparin is given prophylactically to patients to prevent these
    DVT and PE
  13. Laboratory tests used to manage therapeutic range of warfarin
    PTT and INR
  14. The only oral direct thrombin inhibitor
    dabigatran
  15. prototype thrombolytic drug
    alteplase
  16. Prototype vitamin K antagonist
    warfarin
  17. antidote for warfarin
    Vitamin K
  18. prototype Adenosine diphosphate receptor antagonist that irreversibly blocks the ADP receptor on platelet cell surface.
    Clopidogrel
  19. Process that maintains the integrity of the vascular compartment.
    Homeostasis
  20. agents that dissolve blood clots
    Thrombolytic Drugs
  21. Acts in the liver to prevent synthesis of vitamin K
    Action of warfarin
  22. A potentially life-threatening complication of heparin administration leading to a decrease in platelet count and detectable HIT antibodies
    Heparin induced thrombocytopenia (HIT)
  23. An inactive protein present in many body tissues and fluids that is bound to fibrin and becomes a component of a blood clot
    Plasminogen
  24. Reversal of thrombolytic agent used for short periods in patients with hemophilia to prevent or decrease breeding form tooth extraction or menorrhagia.
    tranexamic acid